UroToday3d
ASCO GU 2025: Case-Based Session: Failure of Immunotherapy in Renal Cell Cancer – What’s Next
(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Annual Symposium held in San ...
New findings on tumor reduction and survival outcomes in advanced renal cell carcinoma
Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...
Nature4d
Regression of human metastatic renal cell carcinoma after vaccination with tumor cell–dendritic cell hybrids
Figure 3: Clinical response to hybrid cell vaccination. Our data indicate that hybrid cell vaccination is a safe and effective immune therapy for human metastatic renal cell carcinoma. This ...